The Elelaf Edit

Why Elelaf Won’t Bottle the 2026 Skin Cycling Trend (An Editorial Note)

woman, bar, wine, liquor, the drinks, bottle, a restaurant, glass bottle, buffet, bar counter, beauty, wineglass, drink,

TL;DR

We had a formula brief on the table. A four-product skin-cycling system, ready to ship. We declined. Here is the reasoning: the trend is real, the science is mostly fine, but the product expression of skin cycling is the wrong fit for our editorial position. A protocol does not need a SKU.

In early 2026, our formulation partner sent us a brief for a four-product skin-cycling system. Day one exfoliant, day two retinoid, day three and four recovery. Pre-packaged in a numbered box. The math worked, the unit economics worked, and our agency had laid out a launch path with a six-week social plan and a creator list. I read it twice, sat with it for a week, and wrote back and said no.

What skin cycling is, and why it is fine

Skin cycling, as popularized by Dr. Whitney Bowe in 2022 and 2023, is a structured four-night rotation: exfoliate one night, retinoid the next, then two recovery nights. The premise is sensible. Most people overdo actives. A rotation reduces irritation and lets the barrier recover.

The American Academy of Dermatology has weighed in in measured terms. The 2023 AAD guidance acknowledged that cyclic application of actives is consistent with how dermatologists already prescribe many regimens. PubMed-indexed reviews on retinoid tolerability published in 2022 and 2024 reach similar conclusions about non-daily retinoid dosing. The protocol itself is not the problem. We have written about it in our skin cycling trend autopsy.

So what was the problem with the SKU

Three things. First, the box was solving a problem the user could already solve. The four-night rotation works with any reasonable exfoliant, retinoid, and moisturizer. Most readers already own three of the four. Selling them a numbered box implies that the system only works with our system, which is not true.

Second, the time-lock in the marketing. “Open box one on day one. Open box two on day two.” That cadence has commercial value. It also locks the user into a rhythm that may not be right for their skin. Some people need a six-night cycle. Some need a two-night cycle. Selling the four-night cadence as absolute would have been editorially dishonest.

Third, the trend timing. Skin cycling peaked in late 2024 and early 2025. By the time our SKU would have shipped, twelve to fourteen months later, we would have been launching into a saturated, post-peak market. Five major brands had launched their cycling SKUs already. The honest opportunity was not to add a sixth.

The contrarian section: trend-launched skincare is bad business

The trend launch cycle in skincare is structurally exploitative. The brand reads a social signal, briefs a formula, ships in twelve months, and captures the consumer at the tail of a wave that is already breaking. The consumer ends up with a product that solved a problem they had read about a year ago, often forgotten about, and no longer needs. The unit economics work because the average consumer does not return the product or push back. The brand wins on launch revenue. The consumer loses on shelf clutter and money. The category, over time, loses trust.

Our thesis is the opposite. Fewer products, longer trials, no trend chasing. We wrote it down in the slow skincare manifesto before we had products on a shelf. Saying no to the skin-cycling SKU was a test of whether we meant it.

What we did instead

Two things, both of which cost us less and serve readers better. We published the editorial trend autopsy: a piece that explains the protocol and how to do it with products you probably already own. We updated our existing hero serum guidance so that on rotation nights, it can be used solo or paired with a separate retinoid the reader already has. No new SKU. No four-product box. The cost of saying yes, in editorial credibility and routine bloat, was higher than the revenue we walked away from.

The bar for any new SKU

Three tests. Is there a science territory we have a real position on, that the current shelf does not serve well? Does the product replace something in the routine, rather than adding to it? Would we publish the product’s full mechanism in plain language and feel good about it? The skin-cycling box did not pass the third. The plain version would have read: a rebrand of products you already own, timed to a trend past its peak.

The reader-facing version

If you want to skin cycle, do it. Use the products you already have. The variable that matters is making sure your retinoid and exfoliant are well-formulated and that recovery nights actually let the skin reset. We have written about retinoid introduction, barrier repair, and the broader order of operations. Saving sixty dollars on the numbered box is not the win. The win is the routine that actually works for your skin. For more, see the skinimalism archive.

FAQ

Are you against skin cycling? No. The protocol is sensible. The SKU expression of it was not the right product for our brand to ship.

What’s the harm in a trend-cycle launch? Product bloat, shelf clutter, eroded trust over time, and a category that prioritizes velocity over efficacy.

How do you decide when a trend is worth a product? The science has to be real, the product has to replace something, and the trend timing has to be early enough that we are not the sixth brand in.

Will you ever launch a routine-system box? Possibly. If we did, it would not be tied to a trend cadence; it would be a starter routine at the user’s pace.

What should readers do with this piece? Use it as a signal of how we think. Hold us to the same three-test bar on anything we ever launch.

Sources

AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology guidance on cyclic retinoid use, 2023. PubMed-indexed reviews on retinoid tolerability and non-daily dosing, 2022-2024. Internal Elelaf editorial and formulation correspondence, Q1 2026.